199 related articles for article (PubMed ID: 24623377)
1. A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells.
Moraes CT
EMBO Mol Med; 2014 Apr; 6(4):434-5. PubMed ID: 24623377
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations.
Gammage PA; Rorbach J; Vincent AI; Rebar EJ; Minczuk M
EMBO Mol Med; 2014 Apr; 6(4):458-66. PubMed ID: 24567072
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial DNA disease-molecular insights and potential routes to a cure.
Russell O; Turnbull D
Exp Cell Res; 2014 Jul; 325(1):38-43. PubMed ID: 24675282
[TBL] [Abstract][Full Text] [Related]
4. Progressive External Ophthalmoplegia in Polish Patients-From Clinical Evaluation to Genetic Confirmation.
Kierdaszuk B; Kaliszewska M; Rusecka J; Kosińska J; Bartnik E; Tońska K; Kamińska AM; Kostera-Pruszczyk A
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396418
[TBL] [Abstract][Full Text] [Related]
5. Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.
Tonin Y; Heckel AM; Vysokikh M; Dovydenko I; Meschaninova M; Rötig A; Munnich A; Venyaminova A; Tarassov I; Entelis N
J Biol Chem; 2014 May; 289(19):13323-34. PubMed ID: 24692550
[TBL] [Abstract][Full Text] [Related]
6. Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA.
Minczuk M; Papworth MA; Miller JC; Murphy MP; Klug A
Nucleic Acids Res; 2008 Jul; 36(12):3926-38. PubMed ID: 18511461
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial disorders: Understanding mitochondrial DNA point mutations and deletion syndromes.
Heuer B; Seibert DC
J Am Assoc Nurse Pract; 2022 Aug; 34(8):954-956. PubMed ID: 36330549
[TBL] [Abstract][Full Text] [Related]
8. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells.
Suen DF; Narendra DP; Tanaka A; Manfredi G; Youle RJ
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11835-40. PubMed ID: 20547844
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
10. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs.
Bacman SR; Williams SL; Pinto M; Peralta S; Moraes CT
Nat Med; 2013 Sep; 19(9):1111-3. PubMed ID: 23913125
[TBL] [Abstract][Full Text] [Related]
11. Clinical, pathological and genetic spectrum in 89 cases of mitochondrial progressive external ophthalmoplegia.
Rodríguez-López C; García-Cárdaba LM; Blázquez A; Serrano-Lorenzo P; Gutiérrez-Gutiérrez G; San Millán-Tejado B; Muelas N; Hernández-Laín A; Vílchez JJ; Gutiérrez-Rivas E; Arenas J; Martín MA; Domínguez-González C
J Med Genet; 2020 Sep; 57(9):643-646. PubMed ID: 32161153
[TBL] [Abstract][Full Text] [Related]
12. Defects of mitochondrial DNA replication.
Copeland WC
J Child Neurol; 2014 Sep; 29(9):1216-24. PubMed ID: 24985751
[TBL] [Abstract][Full Text] [Related]
13. Analysis of common mitochondrial DNA mutations by allele-specific oligonucleotide and Southern blot hybridization.
Tang S; Halberg MC; Floyd KC; Wang J
Methods Mol Biol; 2012; 837():259-79. PubMed ID: 22215554
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001.
Marotta R; Chin J; Quigley A; Katsabanis S; Kapsa R; Byrne E; Collins S
Intern Med J; 2004; 34(1-2):10-9. PubMed ID: 14748908
[TBL] [Abstract][Full Text] [Related]
15. Altering the balance between healthy and mutated mitochondrial DNA.
Smith PM; Lightowlers RN
J Inherit Metab Dis; 2011 Apr; 34(2):309-13. PubMed ID: 20506041
[TBL] [Abstract][Full Text] [Related]
16. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes.
Sadikovic B; Wang J; El-Hattab AW; Landsverk M; Douglas G; Brundage EK; Craigen WJ; Schmitt ES; Wong LJ
PLoS One; 2010 Dec; 5(12):e15687. PubMed ID: 21187929
[TBL] [Abstract][Full Text] [Related]
17. Engineered zinc finger proteins for manipulation of the human mitochondrial genome.
Minczuk M
Methods Mol Biol; 2010; 649():257-70. PubMed ID: 20680840
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria.
Tanaka M; Borgeld HJ; Zhang J; Muramatsu S; Gong JS; Yoneda M; Maruyama W; Naoi M; Ibi T; Sahashi K; Shamoto M; Fuku N; Kurata M; Yamada Y; Nishizawa K; Akao Y; Ohishi N; Miyabayashi S; Umemoto H; Muramatsu T; Furukawa K; Kikuchi A; Nakano I; Ozawa K; Yagi K
J Biomed Sci; 2002; 9(6 Pt 1):534-41. PubMed ID: 12372991
[TBL] [Abstract][Full Text] [Related]
19. Transmission of mitochondrial DNA disorders: possibilities for the elimination of mutated mitochondria.
Fulka J; Fulka H; John JC
Cloning Stem Cells; 2007; 9(1):47-50. PubMed ID: 17386013
[TBL] [Abstract][Full Text] [Related]
20. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes.
Alexeyev MF; Venediktova N; Pastukh V; Shokolenko I; Bonilla G; Wilson GL
Gene Ther; 2008 Apr; 15(7):516-23. PubMed ID: 18256697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
